Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors

BACKGROUND: Real‐world data enables evaluation of immune checkpoint inhibitor (ICI) use in advanced melanoma management. We examined characteristics and outcomes of ICI‐treated patients with advanced melanoma and organ dysfunction (baseline and emergent). MATERIALS AND METHODS: This retrospective ob...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Principais autores: Spillane, Susan, Baxi, Shrujal, Torres, Aracelis Z., Lenis, David, Freedman, Andrew N., Mariotto, Angela B., Sharon, Elad
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2020
Assuntos:
Melanoma and Cutaneous Malignancies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7648349/
https://ncbi.nlm.nih.gov/pubmed/33094874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0055
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados